2024-08 |
Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria |
Modern Rheumatology
|
2024-07 |
The Clinical Utility of Serum Alpha-1-Acid Glycoprotein in Reflecting the Cross-Sectional Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Centre Retrospective Study |
Medicina (Kaunas, Lithuania)
|
2024-07 |
Circulating Malondialdehyde Is a Potential Biomarker for Predicting All-Cause Mortality during Follow-Up by Reflecting Comprehensive Inflammation at Diagnosis in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Medicina (Kaunas, Lithuania)
|
2024-07 |
The monocyte-to-high-density lipoprotein-cholesterol ratio at diagnosis is associated with cerebrovascular accident during follow-up in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Journal of Rheumatic Diseases
|
2024-05 |
First-year cumulative myeloperoxidase-ANCA titres are associated with all-cause mortality in patients with microscopic polyangiitis |
Clinical and Experimental Rheumatology
|
2024-05 |
Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis |
Clinical and Experimental Rheumatology
|
2024-05 |
Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria |
The Korean Journal of Internal Medicine
|
2024-04 |
Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis |
Scientific Reports
|
2024-03 |
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Medicina (Kaunas, Lithuania)
|
2024-02 |
Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis |
Zeitschrift für Rheumatologie
|
2024-02 |
Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic |
Zeitschrift für Rheumatologie
|
2024-02 |
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort |
Seminars in Arthritis and Rheumatism
|
2024-01 |
Antineutrophil cytoplasmic antibody‑associated vasculitis classification by cluster analysis based on clinical phenotypes: a single‑center retrospective cohort study |
Clinical Rheumatology
|
2023-12 |
Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis |
Arthritis Research & Therapy
|
2023-11 |
Phonozen-mediated photodynamic therapy comparing two wavelengths in a mouse model of peritoneal carcinomatosis |
Photochemical & Photobiological Sciences
|
2023-11 |
IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
Journal of Clinical Medicine
|
2023-11 |
Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study |
Journal of Clinical Medicine
|
2023-10 |
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19 |
Virology Journal
|
2023-10 |
Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis |
Heliyon
|
2023-10 |
Hepatic steatosis index at diagnosis has the potential for forecasting end-stage kidney disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
대한류마티스학회지
|
2023-10 |
Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
Yonsei Medical Journal
|
2023-09 |
A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis |
Asian Pacific Journal of Allergy and Immunology
|
2023-09 |
Renal histopathological predictors of end‑stage kidney disease in ANCA‑associated vasculitis with glomerulonephritis: a single‑centre study in Korea |
Scientific Reports
|
2023-09 |
Association between computed tomography-assessed sarcopenia and mortality in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
|
2023-09 |
Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
JOURNAL OF CLINICAL MEDICINE
|
2023-09 |
Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Frontiers in Medicine
|
2023-08 |
Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis A Korean Single-Center Study |
Journal of Clinical Rheumatology
|
2023-08 |
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Therapeutic Advances in Musculoskeletal Disease
|
2023-06 |
Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Journal of Clinical Medicine
|
2023-05 |
New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Frontiers in Medicine
|
2023-05 |
Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody–associated vasculitis |
Annals of Clinical Biochemistry
|
2023-04 |
Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis |
Clinical and Experimental Rheumatology
|
2023-04 |
Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis |
Clinical and Experimental Rheumatology
|
2023-04 |
Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis |
Clinical and Experimental Rheumatology
|
2023-04 |
Acute coronary syndrome in antineutrophil cytoplasmic antibody-associated vasculitis: a Korean single-centre cohort study |
Journal of Rheumatic Diseases
|
2023-04 |
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines |
Journal of Rheumatic Diseases
|
2023-03 |
Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria |
Rheumatology (United Kingdom)
|
2023-02 |
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis |
Journal of Rheumatology
|
2023-01 |
Cancer-associated vasculitides: a single-centre case series |
CLINICAL RHEUMATOLOGY
|
2023-01 |
Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center |
대한류마티스학회지
|
2023-01 |
Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria |
Yonsei Medical Journal
|
2022-12 |
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
Scientific Reports
|
2022-11 |
Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review |
JOURNAL OF CLINICAL MEDICINE
|
2022-11 |
Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis |
Korean Journal of Internal Medicine
|
2022-11 |
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis |
Scientific Reports
|
2022-11 |
Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
In Vivo
|
2022-11 |
BVAS version 3 and BVAS/GPA: standing on the same line? |
CLINICAL RHEUMATOLOGY
|
2022-10 |
Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis |
Annals of Palliative Medicine
|
2022-10 |
Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis |
Zeitschrift fur Rheumatologie
|
2022-09 |
2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al |
Annals of the Rheumatic Diseases
|
2022-08 |
Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody‑associated vasculitis in non‑diabetic patients |
BMC NEPHROLOGY
|
2022-07 |
Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
Journal of Rheumatic Diseases
|
2022-07 |
Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
JOURNAL OF RENAL NUTRITION
|
2022-07 |
Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2 |
Journal of Clinical Medicine
|
2022-07 |
Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
2022-07 |
Serum albumin, prealbumin, and ischemiamodified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study |
PLOS ONE
|
2022-07 |
Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002–2018 South Korea National Health Insurance Database |
Frontiers in medicine
|
2022-06 |
Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease |
FRONTIERS IN CARDIOVASCULAR MEDICINE
|
2022-06 |
Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Diagnostics
|
2022-05 |
Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single- Centre Observational Study |
JOURNAL OF IMMUNOLOGY RESEARCH
|
2022-05 |
New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
2022-05 |
Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
2022-05 |
Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
2022-04 |
Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea |
Stroke and Vasular Neurology
|
2022-04 |
Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Medicina (Kaunas, Lithuania)
|
2022-04 |
Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? |
RHEUMATOLOGY
|
2022-04 |
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience |
LUPUS
|
2022-04 |
Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis |
Journal of Clinical Medicine
|
2022-03 |
Aortic valve surgery in patients with Takayasu’s arteritis: a nationwide analysis of 1,197 patients during a 9-year period |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
2022-03 |
A retrospective analysis of antineutrophil cytoplasmic antibodyassociated vasculitis aiming for an equation prediction end-stage renal disease |
CLINICAL RHEUMATOLOGY
|
2022-02 |
Clinical application of low erythrocyte sedimentation rate/ high C-reactive protein to antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
2022-02 |
Serum vitamin D level correlates with disease activity and healthrelated quality of life in antineutrophil cytoplasmic antibody-associated vasculitis |
ZEITSCHRIFT FUR RHEUMATOLOGIE
|
2022-02 |
Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody‑associated vasculitis |
RHEUMATOLOGY INTERNATIONAL
|
2022-01 |
Drug Survival of Biologic Therapy in Elderly Patients With Rheumatoid Arthritis Compared With Nonelderly Patients Results From the Korean College of Rheumatology Biologics Registry |
Journal of Clinical Rheumatology
|
2022-01 |
Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis |
Journal of Rheumatic Diseases
|
2021-12 |
Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Journal of Clinical Medicine
|
2021-12 |
Prevalence of Osteopenia in Drug-Naive Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis A Monocentric Study |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
|
2021-11 |
Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
2021-11 |
Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
YONSEI MEDICAL JOURNAL
|
2021-10 |
Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis |
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
|
2021-09 |
Evaluation of body composition using computed tomography in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2021-09 |
Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis |
MEDICINE
|
2021-09 |
Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody–associated vasculitis |
CLINICAL RHEUMATOLOGY
|
2021-08 |
Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis |
JOURNAL OF CLINICAL LABORATORY ANALYSIS
|
2021-08 |
Systemic inflammation response index predicts all‑cause mortality in patients with antineutrophil cytoplasmic antibody‑associated vasculitis |
INTERNATIONAL UROLOGY AND NEPHROLOGY
|
2021-07 |
Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
2021-07 |
Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
MEDIATORS OF INFLAMMATION
|
2021-07 |
Fibrosis‑5 predicts end‑stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis without substantial liver diseases |
CLINICAL AND EXPERIMENTAL MEDICINE
|
2021-07 |
Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis |
PLOS ONE
|
2021-06 |
The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis |
YONSEI MEDICAL JOURNAL
|
2021-05 |
Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
2021-05 |
Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis |
KOREAN JOURNAL OF INTERNAL MEDICINE
|